AllI · Sterile fill-finish capacityII · Stoppers, syringes & drug-contact componentsIII · Pharmaceutical glass & vialsIV · Bioprocessing consumables & resinsV · API & small-molecule reshoringVI · CDMO capacity & the China exodusVII · Peptide & oligonucleotide manufacturingVIII · Sterile injectables & shortage economicsIX · Analytical instruments & QC releaseX · Private giants & exposure vehicles
| Ticker | Name | Tier ↓ | Quote | Mkt cap | 6M | Chokepoints |
|---|---|---|---|---|---|---|
| A | Agilent Technologies, Inc. | core | $173.07-0.5% | $37.0B | +49.8% | peptides-oligos · instruments-qc |
| BAX | Baxter International Inc. | core | $25.30-1.4% | $10.0B | +39.3% | sterile-injectables-shortages |
| BCHMY | Bachem Holding AG (ADR) | core | $10.00-2.1% | $6.7B | +10.9% | peptides-oligos |
| DAIKYOSEIKO | Daikyo Seiko, Ltd. | core | private | — | via WST | private-giants |
| DHR | Danaher Corporation | core | $230.50+0.3% | $128.0B | +30.0% | bioprocessing · instruments-qc |
| HKMPY | Hikma Pharmaceuticals PLC | core | $44.35+0.0% | $4.2B | +19.2% | api-reshoring · sterile-injectables-shortages |
| ICUI | ICU Medical, Inc. | core | $166.62-1.0% | $3.4B | +33.5% | sterile-injectables-shortages |
| LLY | Eli Lilly and Company | core | $1273.46-2.5% | $1.0T | +44.1% | fill-finish |
| LZAGY | Lonza Group AG (unsponsored ADR) | core | $76.54-0.2% | $41.9B | +24.2% | fill-finish · api-reshoring · cdmo-capacity · peptides-oligos · private-giants |
| NVO | Novo Nordisk A/S | core | $39.05-1.0% | $195.0B | -5.1% | fill-finish · private-giants |
| RGEN | Repligen Corporation | core | $176.93-1.0% | $7.4B | +50.5% | bioprocessing |
| SHTPY | SCHOTT Pharma AG & Co. KGaA (ADR) | core | $6.55-0.0% | $2.8B | +49.9% | pharma-glass |
| STVN | Stevanato Group S.p.A. | core | $19.49-0.1% | $5.0B | +20.5% | drug-packaging-components · pharma-glass · private-giants |
| TMO | Thermo Fisher Scientific Inc. | core | $673.82-0.4% | $180.0B | +43.5% | fill-finish · bioprocessing · api-reshoring · cdmo-capacity · instruments-qc |
| WAT | Waters Corporation | core | $453.67-0.4% | $36.0B | +46.4% | instruments-qc |
| WST | West Pharmaceutical Services, Inc. | core | $392.15-0.5% | $23.0B | +28.1% | drug-packaging-components · private-giants |
| AMPH | Amphastar Pharmaceuticals, Inc. | watch | $25.14-3.5% | $856M | +17.4% | sterile-injectables-shortages |
| AMRX | Amneal Pharmaceuticals, Inc. | watch | $20.38-0.5% | $5.2B | +62.8% | api-reshoring · sterile-injectables-shortages |
| ATR | AptarGroup, Inc. | watch | $126.55-1.2% | $7.3B | +2.0% | drug-packaging-components |
| BMXMF | bioMerieux S.A. | watch | $99.63+0.1% | $8.6B | -5.5% | instruments-qc |
| CORDENPHARMA | CordenPharma (Astorg) | watch | private | — | via — | peptides-oligos |
| CRL | Charles River Laboratories International, Inc. | watch | $345.37+1.7% | $8.9B | +103.4% | cdmo-capacity · instruments-qc |
| FSNUY | Fresenius SE & Co. KGaA (ADR) | watch | $12.88+0.9% | $24.0B | +8.6% | sterile-injectables-shortages |
| FUJIY | FUJIFILM Holdings Corporation (ADR) | watch | $10.76-0.2% | $26.7B | +19.2% | fill-finish · cdmo-capacity |
| GLW | Corning Incorporated | watch | $123.69-0.2% | $153.0B | -29.7% | pharma-glass |
| MKKGY | Merck KGaA (MilliporeSigma) | watch | $32.08-2.5% | $62.3B | +21.8% | bioprocessing |
| MTD | Mettler-Toledo International | watch | $1670.29-0.9% | $23.0B | +30.2% | instruments-qc |
| PLYGF | PolyPeptide Group AG | watch | $54.42+0.0% | $1.5B | +19.6% | private-giants |
| RDY | Dr. Reddy's Laboratories Ltd | watch | $13.21-0.2% | $11.1B | -3.4% | api-reshoring |
| SAMSUNGBIOLOGICS | Samsung Biologics Co., Ltd. | watch | private | — | via — | cdmo-capacity |
| SDMHF | Sartorius Stedim Biotech S.A. | watch | $239.000.0% | $18.8B | +26.4% | bioprocessing |
| SGFEF | Siegfried Holding AG | watch | $88.12+0.0% | $4.0B | -11.9% | api-reshoring · private-giants |
| SHLMEDICAL | SHL Medical AG | watch | private | — | via — | drug-packaging-components |
| WXIBF | WuXi Biologics (Cayman) Inc. | watch | $6.32+18.4% | $15.9B | +34.5% | cdmo-capacity |
| GRRMF | Gerresheimer AG | speculative | $36.00+6.2% | $920M | +74.3% | pharma-glass |
| GRRMY | Gerresheimer AG (ADR) | speculative | $8.30-0.0% | $920M | +59.6% | drug-packaging-components |
| MRVI | Maravai LifeSciences Holdings, Inc. | speculative | $7.32+3.5% | $1.4B | +106.2% | peptides-oligos |
| NPEGF | Nippon Electric Glass Co., Ltd. | speculative | $29.20-0.0% | $3.6B | -27.6% | pharma-glass |
| SIMTRA | Simtra BioPharma Solutions | speculative | private | — | via — | fill-finish |
| SOAGY | Sartorius Aktiengesellschaft | speculative | $63.26+2.6% | $13.8B | +23.2% | bioprocessing |
| USANTIBIOTICS | USAntibiotics | speculative | private | — | via — | api-reshoring |
| VTRS | Viatris Inc. | speculative | $18.00-2.6% | $19.0B | +23.4% | sterile-injectables-shortages |
| WUXAY | WuXi AppTec Co., Ltd. | speculative | $23.71-0.8% | $42.0B | +53.0% | api-reshoring · cdmo-capacity |
| YPHDF | Ypsomed Holding AG | speculative | $436.55-0.0% | $4.9B | +23.0% | drug-packaging-components |
Quote shows the latest price and daily change; the 6M column is the total return over that window. Quotes delayed up to 15 minutes; tiers are editorial conviction, not ratings. Click a column header to sort.